Taken together, these results suggested that APOBEC3G interferes with TGFβ signaling by affecting Smad2 phosphorylation and Smad2 downstream target gene expression, which may account for APOBEC3G mediated proliferation and migration in mesenchymal GICs and GBM Cells. Here, APOBEC3G is linked to glioblastoma.